| Product Code: ETC9959367 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant decline in antivenom import shipments in 2024, with top exporting countries including Austria, Metropolitan France, Italy, Germany, and Brazil. The market remained fairly fragmented with very low concentration, indicating opportunities for diversification. The compound annual growth rate (CAGR) from 2020 to 2024 was notably negative at -31.87%, with a further decline in growth rate from 2023 to 2024 at -39.06%. This trend suggests a challenging landscape for antivenom imports into the USA, potentially influenced by various factors impacting demand and supply chains.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Antivenoms Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Antivenoms Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Antivenoms Market - Industry Life Cycle |
3.4 United States (US) Antivenoms Market - Porter's Five Forces |
3.5 United States (US) Antivenoms Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Antivenoms Market Revenues & Volume Share, By Species, 2022 & 2032F |
3.7 United States (US) Antivenoms Market Revenues & Volume Share, By Mode of Action, 2022 & 2032F |
3.8 United States (US) Antivenoms Market Revenues & Volume Share, By End-User, 2022 & 2032F |
4 United States (US) Antivenoms Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of snake bites in the United States |
4.2.2 Growing awareness about the importance of rapid treatment with antivenoms |
4.2.3 Advancements in technology leading to the development of more effective antivenoms |
4.3 Market Restraints |
4.3.1 Regulatory challenges in the approval and distribution of antivenoms |
4.3.2 Limited availability of specialized healthcare facilities for snake bite treatment |
4.3.3 High cost associated with antivenom treatments |
5 United States (US) Antivenoms Market Trends |
6 United States (US) Antivenoms Market, By Types |
6.1 United States (US) Antivenoms Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Antivenoms Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 United States (US) Antivenoms Market Revenues & Volume, By Polyvalent, 2022 - 2032F |
6.1.4 United States (US) Antivenoms Market Revenues & Volume, By Monovalent, 2022 - 2032F |
6.1.5 United States (US) Antivenoms Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Antivenoms Market, By Species |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Antivenoms Market Revenues & Volume, By Snake, 2022 - 2032F |
6.2.3 United States (US) Antivenoms Market Revenues & Volume, By Spider, 2022 - 2032F |
6.2.4 United States (US) Antivenoms Market Revenues & Volume, By Scorpion, 2022 - 2032F |
6.2.5 United States (US) Antivenoms Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 United States (US) Antivenoms Market, By Mode of Action |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Antivenoms Market Revenues & Volume, By Cytotoxic, 2022 - 2032F |
6.3.3 United States (US) Antivenoms Market Revenues & Volume, By Neurotoxic, 2022 - 2032F |
6.3.4 United States (US) Antivenoms Market Revenues & Volume, By Haemotoxic, 2022 - 2032F |
6.3.5 United States (US) Antivenoms Market Revenues & Volume, By Cardiotoxic, 2022 - 2032F |
6.3.6 United States (US) Antivenoms Market Revenues & Volume, By Myotoxic, 2022 - 2032F |
6.3.7 United States (US) Antivenoms Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 United States (US) Antivenoms Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Antivenoms Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.3 United States (US) Antivenoms Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.4 United States (US) Antivenoms Market Revenues & Volume, By Ambulatory surgical centers, 2022 - 2032F |
6.4.5 United States (US) Antivenoms Market Revenues & Volume, By Others, 2022 - 2032F |
7 United States (US) Antivenoms Market Import-Export Trade Statistics |
7.1 United States (US) Antivenoms Market Export to Major Countries |
7.2 United States (US) Antivenoms Market Imports from Major Countries |
8 United States (US) Antivenoms Market Key Performance Indicators |
8.1 Average time from diagnosis to administration of antivenom |
8.2 Number of research studies and clinical trials on new antivenom products |
8.3 Percentage of healthcare professionals trained in snake bite management and antivenom administration |
9 United States (US) Antivenoms Market - Opportunity Assessment |
9.1 United States (US) Antivenoms Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Antivenoms Market Opportunity Assessment, By Species, 2022 & 2032F |
9.3 United States (US) Antivenoms Market Opportunity Assessment, By Mode of Action, 2022 & 2032F |
9.4 United States (US) Antivenoms Market Opportunity Assessment, By End-User, 2022 & 2032F |
10 United States (US) Antivenoms Market - Competitive Landscape |
10.1 United States (US) Antivenoms Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Antivenoms Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here